Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trials Not Allowed)
ID: 358892Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Private Institutions of Higher Education

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a limited competition cooperative agreement opportunity titled "Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trials Not Allowed)." This funding aims to provide essential operations support for the NBLs located at the University of Texas Medical Branch in Galveston, Texas, and Boston University, focusing on facility maintenance, biosecurity, environmental health and safety, regulatory compliance, and specialized research support services. The NBLs play a crucial role in conducting research on hazardous biological agents, supporting biodefense efforts, and preparing for national emergencies related to infectious diseases. The total anticipated funding for this opportunity is $23 million for two awards in FY 2026, with applications due by November 7, 2025. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services (HHS) and the National Institutes of Health (NIH) are reissuing a Notice of Funding Opportunity (NOFO), RFA-AI-25-013, to continue providing operations support for the National Biocontainment Laboratories (NBLs) at the University of Texas Medical Branch and Boston University. This limited competition cooperative agreement (UC7) aims to maintain essential infrastructure for conducting research on hazardous biological agents, supporting NIAID's biodefense efforts, and preparing for national biodefense emergencies. The NOFO details requirements for facility maintenance, biosecurity, environmental health and biosafety, regulatory compliance, and specialized research support services through various cores. It allows only one application per institution, with a maximum project period of five years and an anticipated total funding of $23 million for two awards in FY 2026. Clinical trials are not allowed. The application process involves specific instructions for multi-component submissions and adherence to NIH's grants policies.
    Similar Opportunities
    Loading similar opportunities...